ASND
Ascendis Pharma A/s Health Care Pharmaceutical Preparations Russell 3000
$251.27Close
$196.01 – $277.1852-week range
Nov 11, 2026Next report
Highlights
Cautions
- Trend not confirmed 6 of 8 conditions · under 30% off the low, RS under 70
- Results soon Nov 11, 2026, in 10 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
2.5%
$6.28 a day · 2×ATR $238.72
RS
64 / 99
vs the universe
Trend
6 / 8
under 30% off the low, RS under 70
Relative volume
0.5×
vs 50-day average
Up/down volume
0.95
50 sessions
Implied move
—
no option chain · report Nov 11, 2026
Trend template · 6 of 8
- At least 30% above the 52-week low: fails
- RS rank 70 or higher: fails
Screen verdict
Not scorable — no classified balance sheet.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Feb 11, 2026 | Annual ↗ | — | 0d |
| Feb 12, 2025 | Annual ↗ | — | 0d |
| Feb 7, 2024 | Annual ↗ | — | 0d |
| Feb 16, 2023 | Annual ↗ | — | 0d |
| Mar 2, 2022 | Annual ↗ | — | 0d |
| Mar 10, 2021 | Annual ↗ | — | 0d |
| Apr 3, 2020 | Annual ↗ | — | 0d |
| Apr 3, 2019 | Annual ↗ | — | 0d |
| Mar 28, 2018 | Annual ↗ | — | 0d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 26, 2026 | Foreign issuer report ↗ |
| Oct 16, 2026 | Foreign issuer report ↗ |
| Oct 14, 2026 | Foreign issuer report ↗ |
| Sep 29, 2026 | Foreign issuer report ↗ |
| Sep 15, 2026 | Foreign issuer report ↗ |
| Sep 15, 2026 | Foreign issuer report ↗ |
| Sep 9, 2026 | Foreign issuer report ↗ |
| Sep 9, 2026 | Foreign issuer report ↗ |
| Aug 31, 2026 | Foreign issuer report ↗ |
| Aug 13, 2026 | Foreign issuer report ↗ |
| Aug 13, 2026 | Foreign issuer report ↗ |
| Aug 12, 2026 | Foreign issuer report ↗ |